OM (Outset Medical) Debt-to-Equity : 7.53 (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Outset Medical Debt-to-Equity?

Outset Medical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $1.8 Mil. Outset Medical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $200.1 Mil. Outset Medical's Total Stockholders Equity for the quarter that ended in Dec. 2024 was $26.8 Mil. Outset Medical's debt to equity for the quarter that ended in Dec. 2024 was 7.53.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Outset Medical's Debt-to-Equity or its related term are showing as below:

OM' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.1 Med: 0.12 Max: 7.53
Current: 7.53

During the past 7 years, the highest Debt-to-Equity Ratio of Outset Medical was 7.53. The lowest was -0.10. And the median was 0.12.

OM's Debt-to-Equity is ranked worse than
98.99% of 695 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs OM: 7.53

Outset Medical Debt-to-Equity Historical Data

The historical data trend for Outset Medical's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Outset Medical Debt-to-Equity Chart

Outset Medical Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Debt-to-Equity

Get a 7-Day Free Trial

0.12

0.10

0.42

1.11

7.53

Outset Medical Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Debt-to-Equity	Get a 7-Day Free Trial															1.11	2.17	2.95	4.23	7.53

Competitive Comparison of Outset Medical's Debt-to-Equity

For the Medical Devices subindustry, Outset Medical's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Outset Medical's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Outset Medical's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Outset Medical's Debt-to-Equity falls into.

Save Embed

;

Save Embed

;

Outset Medical Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Outset Medical's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.799	+	200.059)	/	26.819
	=	7.53

Outset Medical's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.799	+	200.059)	/	26.819
	=	7.53

Outset Medical (NAS:OM) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Outset Medical Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Outset Medical's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Outset Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Outset Medical Inc (NAS:OM) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

3052 Orchard Drive, San Jose, CA, USA, 95134

Website

https://www.outsetmedical.com

Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.

Executives

John L. Brottem	officer: General Counsel	3052 ORCHARD DR., SAN JOSE CA 95134
Leslie Trigg	director, officer: President & CEO	C/O OUTSET MEDICAL, 1830 BERING ROAD, SAN JOSE CA 95112
Marc Nash	officer: SVP, Operations and R&D	3052 ORCHARD DRIVE, SAN JOSE CA 95134
Nabeel Ahmed	officer: Interim CFO	3052 ORCHARD DRIVE, SAN JOSE CA 95134
D Keith Grossman	director
Jean-olivier Racine	officer: Chief Technology Officer	3052 ORCHARD DRIVE, SAN JOSE CA 95134
Steven S. Williamson	officer: Chief Commercial Officer	C/O HOLOGIC, INC., BEDFORD MA 01730
Stacey L. Porter	officer: Chief People Officer	3052 ORCHARD DRIVE, SAN JOSE CA 95134
Martin Vazquez	officer: Chief Operating Officer	3052 ORCHARD DR., SAN JOSE CA 95134
James F. Hinrichs	director	3750 TORREY VIEW COURT, SAN DIEGO CA 92130
Dale E Jones	director	C/O HUGHES SUPPLY INC, 20 N ORANGE AVE, ORLANDO FL 32801
Rebecca Chambers	officer: Chief Financial Officer	3052 ORCHARD DR., SAN JOSE CA 95134
Catherine M. Szyman	director	C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614
Warburg Pincus Llc	director, 10 percent owner	450 LEXINGTON AVENUE, NEW YORK NY 10017
Warburg Pincus X, L.p.	director, 10 percent owner	C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017